A new study presents a promising treatment for restoring the sense of smell in long-COVID patients. The study explores the effectiveness of CT-guided stellate ganglion block, a minimally invasive procedure, in treating parosmia--a condition affecting up to 60% of COVID-19 patients where the sense of smell is distorted.
A new study presents a promising treatment for restoring the sense of smell in long-COVID patients. The study explores the effectiveness of CT-guided stellate ganglion block, a minimally invasive procedure, in treating parosmia--a condition affecting up to 60% of COVID-19 patients where the sense of smell is distorted.
Share this Article
Recommended